norethindrone has been researched along with algestone acetophenide in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (54.55) | 18.7374 |
1990's | 5 (45.45) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vecchio, TJ | 1 |
Angel de Toro, LA; Lavarello, AC; Roncales Mateo, JM; Sagasta, CL; Salas Diaz, R; Wiemeyer, JC | 1 |
Alba, VM; Alvarado, G; Bassol, S; Cravioto, MC; Garza-Flores, J; Hernandez, L; Perez-Palacios, G; Recio, R; Rivera, R | 1 |
Ammar, R; el-Mahgoub, S; Ghareeb, A; Karem, M | 1 |
Astrup, T; Brakman, P; Sobrero, AJ | 1 |
el-Mahgoub, S | 1 |
Toppozada, MK | 1 |
Sang, GW | 1 |
Koetsawang, S | 1 |
Giwa-Osagie, OF | 1 |
Hefnawi, F; Kandil, OF; Sabry, I; Wassef, SA; Younis, N | 1 |
5 review(s) available for norethindrone and algestone acetophenide
Article | Year |
---|---|
Long-acting injectable contraceptives.
Topics: Adrenal Glands; Algestone Acetophenide; Animals; Blood Pressure; Carbohydrate Metabolism; Cervix Mucus; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrium; Female; Gonadotropins; Growth Hormone; Humans; Injections; Lactation; Medroxyprogesterone; Menstruation; Norethindrone; Ovary; Oviducts; Ovulation; Pregnancy; Vaginal Smears | 1976 |
Existing once-a-month combined injectable contraceptives.
Topics: Algestone Acetophenide; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Latin America; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1994 |
Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Carbohydrate Metabolism; Contraceptive Agents, Female; Estradiol; Female; Hemostasis; Humans; Hydroxyprogesterones; Injections; Lipid Metabolism; Medroxyprogesterone Acetate; Norethindrone | 1994 |
2 trial(s) available for norethindrone and algestone acetophenide
Article | Year |
---|---|
Multicentred clinical study of the metabolic effect of the monthly injectable contraceptive containing dihydroxyprogesterone acetophenide 150 mg + estradiol enanthate 10 mg.
Topics: Adult; Algestone; Algestone Acetophenide; Analysis of Variance; Ceruloplasmin; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Copper; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Injections; Levonorgestrel; Multicenter Studies as Topic; Norethindrone; Norgestrel; Sex Hormone-Binding Globulin; Testosterone; Transcortin; Triglycerides; White People | 1990 |
Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
Topics: Adult; Algestone Acetophenide; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Estradiol; Female; Humans; Injections; Intrauterine Devices, Copper; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Prolactin; Random Allocation | 1989 |
4 other study(ies) available for norethindrone and algestone acetophenide
Article | Year |
---|---|
The effects of injectable contraceptives on the direct thyroid function tests.
Topics: Adult; Algestone Acetophenide; Contraceptives, Oral; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norethindrone; Thyroid Function Tests | 1972 |
Effects of different systemic contraceptives on blood fibrinolysis.
Topics: Adult; Algestone Acetophenide; Blood Coagulation Tests; Contraceptives, Oral; Estradiol; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Fibrinogen; Fibrinolysis; Humans; Medroxyprogesterone; Mestranol; Middle Aged; Norethindrone; Norethynodrel; Plasminogen; Pregnancy; Pregnanes; Progestins | 1970 |
Body weight and cycle control of injectable contraceptives.
Topics: Adolescent; Adult; Algestone Acetophenide; Body Weight; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections; Lynestrenol; Medroxyprogesterone; Menstruation; Norethindrone; Norpregnenes; Postpartum Period; Pregnancy; Time Factors | 1980 |
Ovarian changes during and after long term steroid contraceptive therapy.
Topics: Age Factors; Algestone Acetophenide; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Ethinyl Estradiol; Family Planning Services; Genitalia; Genitalia, Female; Histology; Injections; Lynestrenol; Mestranol; Norethindrone; Ovary; Parity; Physiology; Population; Population Dynamics; Time; Time Factors; Urogenital System | 1970 |